About this trial
External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed.
Eligibility criteria
Qualifiers
Age >= 18 years old
Diagnosed with stable angina pectoris
Anatomic vessel disease (VD) lesion with 2VD/3VD
Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery.
Disqualifiers
Congestive Heart Failure
Chronic heart failure with Functional Class NYHA III - IV
LVEF <35%
Unprotected left main stenosis >50%
Trial design
Treatments tested in this trial
- External Counter Pulsation (ECP) therapy